n-vinyl-2-pyrrolidinone has been researched along with Viral Conjunctivitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aslan Sirakaya, H; Sahiner, M; Sirakaya, E | 1 |
| Abe, RY; Arieta, CE; Bonon, SH; de Castro, RS; Felix, JP; Lira, RP; Pereira, AV; Pinto, RD; Zacchia, RS | 1 |
1 trial(s) available for n-vinyl-2-pyrrolidinone and Viral Conjunctivitis
| Article | Year |
|---|---|
Dexamethasone/Povidone Eye Drops versus Artificial Tears for Treatment of Presumed Viral Conjunctivitis: A Randomized Clinical Trial.
Topics: Adenoviridae; Adolescent; Adult; Child; Conjunctivitis, Viral; Dexamethasone; DNA, Viral; Eye Infections, Viral; Female; Follow-Up Studies; Glucocorticoids; Humans; Lubricant Eye Drops; Male; Ophthalmic Solutions; Povidone; Prospective Studies; Single-Blind Method; Treatment Outcome; Young Adult | 2015 |
1 other study(ies) available for n-vinyl-2-pyrrolidinone and Viral Conjunctivitis
| Article | Year |
|---|---|
A Patient With Bilateral Conjunctivitis Positive for SARS-CoV-2 RNA in a Conjunctival Sample.
Topics: Administration, Ophthalmic; Administration, Oral; Adult; Antirheumatic Agents; Antiviral Agents; Conjunctiva; Conjunctivitis, Viral; COVID-19; COVID-19 Drug Treatment; COVID-19 Nucleic Acid Testing; Drug Therapy, Combination; Eye Infections, Viral; Ganciclovir; Humans; Hydroxychloroquine; Intraocular Pressure; Male; Nasopharynx; Pharmaceutic Aids; Povidone; RNA, Viral; SARS-CoV-2; Slit Lamp Microscopy; Visual Acuity | 2021 |